Sopheon PLC
28 November 2002
FOR IMMEDIATE RELEASE 28 November 2002
SOPHEON PLC
NEW ORDERS AND Q3 TRADING UPDATE
In accordance with the requirements of the Euronext Amsterdam stock exchange,
Sopheon plc ('Sopheon'; stock code : SPE) issues its trading update for the
third quarter of 2002 together with further information on new business
development.
Within the Business Process Solutions (BPS) division, Sopheon's flagship
Accolade solution has continued to show real progress in the face of an economic
environment which remains stubbornly challenging. The interim statement released
at the end of August noted that four new licence orders and four pilots had been
concluded since the start of the year. At the end of November this has been
extended by a further three full licence orders including the substantial sale
to Pall Corporation announced in October, and six pilot installations or
assessment studies. To date, all assessments have converted, or are on track to
convert, into full licence sales. In addition, the pipeline of opportunities to
close in the remaining month of the year remains substantial, with both new
licence and extension activity anticipated. While there is much work to do, all
efforts are focused on securing the business required to achieve expectations
and secure a sound footing for 2003. In support of this, the installed licence
base for Accolade provides an increasingly broad and deep reference base.
Certain Accolade customers have also taken up subscriptions or projects with the
group's more traditional Information Management (IM) services, validating the
strategic fit of this independently managed business. Nevertheless, as
previously announced, the core IM business was affected coming out of 2001 both
by the economic climate and by customer M&A activity, in Germany in particular.
These challenges have been met by new sales and product initiatives, as well as
organisational change, and there are signs that the business is recovering with
subscription renewal rates increased compared to the prior year.
The drive to reduce cash burn has remained at the top of the board's agenda; the
need to achieve positive cash flow generation and to sustain cash resources
remain key ongoing priorities. As well as looking to revenue growth in the short
term, from Accolade in particular, control of the cost base remains focused.
Since January 2002, the total headcount has been reduced by approximately 70
people to around 190 today, the majority of this adjustment taking place in the
third quarter following the successful release of Accolade 4.0 and completion of
other integration activities linked to Sopheon's acquisitions in 2001. This
compares with a total of approximately 350 employees a year ago. The board will
continue to seek to match resources to business expectations as we go forward
into 2003.
Other major developments announced in the third quarter include the appointment
of Seymour Pierce Limited as the Company's nominated adviser and broker, and the
appointment of Dan Metzger, a senior and experienced veteran of the ERP and
Collaborative Software industry, as a non-executive director.
Andy Michuda CEO of Sopheon said: 'We remain on course to become a leading
supplier of software and expert services that enable major corporations to
improve critical processes within R&D, and new product development in
particular. Momentum is building with Accolade which, in line with our overall
strategy, should pull through the group's other services. Our
ever-strengthening base of reference clients and the high level of market
interest in our solution continue to affirm our expectations that the pace will
accelerate in the near term and deliver the improved returns that we and our
shareholders require.'
About Sopheon
Sopheon (LSE:SPE) is an international provider of software tools, experts and
content that help organizations improve the business impact of product
development. Sopheon serves nearly half of the technology-driven companies on
the Fortune 500, enabling higher, faster return on innovation and product
development investments through technology and human-based decision support. The
company's products and services include its flagship Accolade(R) product
development system, the award-winning Teltech.com(R) Web-based research portal
for technical and business professionals, and Organik(R) expertise-sharing
software. Sopheon is listed on the Alternative Investment Market of the London
Stock Exchange and on the Euronext in the Netherlands. For more information,
please visit www.sopheon.com.
For further information contact :
Barry Mence, Chairman Sopheon plc Tel : + 44 (0)1483-883000
Arif Karimjee, CFO Sopheon plc Tel : + 44 (0)1483-883000
Steve Liebmann Buchanan Communications Tel : + 44 (0)207-466-5000
Barbara Jansen Citigate First Financial Tel : + 31 (0)205-754-010
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.